ProShare Advisors’s ACELYRIN SLRN Stock Holding History

ProShare Advisors’s Portfolio SLRN Stock Details SLRN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-20,570	Closed	-$50.8K	–	2174
2025 Q1	$50.8K	Sell	20,570 -4,737	-19%	-$11.3K	﹤0.01%	1955
2024 Q4	$79.5K	Buy	25,307 +5,617	+29%	+$27.2K	﹤0.01%	2111
2024 Q3	$97.1K	Buy	19,690 +3,849	+24%	+$19.9K	﹤0.01%	1889
2024 Q2	$69.9K	Sell	15,841 -4,030	-20%	-$18.9K	﹤0.01%	1708
2024 Q1	$134K	Buy	19,871 +8,176	+70%	+$62.1K	﹤0.01%	1767
2023 Q4	$87.2K	Buy	+11,695	New	+$99.8K	﹤0.01%	1799

Other funds holding SLRN

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

ProShare Advisors's SLRN Position: Q2 2025 in Review

ProShare Advisors sold out of ACELYRIN (SLRN) in Q2 2025, closing a stake of 20,570 shares — an estimated $50.8K sold.

ProShare Advisors first reported a position in SLRN in Q4 2023 and held it in 6 quarters. The position peaked at $134K in Q1 2024. 2 funds tracked by Wall St. Rank hold SLRN as of Q2 2025.

ProShare Advisors reported no remaining ACELYRIN position as of Q2 2025 after selling out during the quarter.
ProShare Advisors sold 20,570 ACELYRIN shares in Q2 2025, an estimated $50.8K.
ProShare Advisors first reported a position in ACELYRIN in Q4 2023 and held it in 6 quarters.
ProShare Advisors's ACELYRIN position peaked at $134K in Q1 2024.
2 funds tracked by Wall St. Rank held ACELYRIN as of Q2 2025.

Based on ProShare Advisors's 13F filing for Q2 2025, filed 7 Aug 2025.